These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The effect of some hallucinogenic drugs on the amino acid precursors of brain monoamines. Tonge SR; Leonard BE Life Sci I; 1970 Dec; 9(23):1327-35. PubMed ID: 5493000 [No Abstract] [Full Text] [Related]
24. Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat. Schoenfeld RI Science; 1976 May; 192(4241):801-3. PubMed ID: 1063447 [TBL] [Abstract][Full Text] [Related]
25. The effects of hallucinogens on blind monkeys. Siegel RK; Brewster JM; Johnson CA; Jarvik ME Int Pharmacopsychiatry; 1976; 11(3):150-6. PubMed ID: 11193 [TBL] [Abstract][Full Text] [Related]
27. Evidence for the action of d-lysergic acid diethylamide, mescaline and bufotenine on 5-hydroxytryptamine receptors in umbilical vasculature. Dyer DC J Pharmacol Exp Ther; 1974 Feb; 188(2):336-41. PubMed ID: 4359552 [No Abstract] [Full Text] [Related]
28. Some observations on the behavioural effects of hallucinogenic drugs on rats: potentiation by two drugs affecting monoamine metabolism. Tonge SR; Leonard BE Arch Int Pharmacodyn Ther; 1972 Jan; 195(1):168-76. PubMed ID: 5010826 [No Abstract] [Full Text] [Related]
29. EEG effects of hallucinogens and cannabinoids using sleep-waking behavior as baseline. Fairchild MD; Jenden DJ; Mickey MR; Yale C Pharmacol Biochem Behav; 1980 Jan; 12(1):99-105. PubMed ID: 6102770 [TBL] [Abstract][Full Text] [Related]
32. Discriminable stimuli produced by hallucinogens. Kuhn DM; White FJ; Appel JB Psychopharmacol Commun; 1976; 2(4):345-8. PubMed ID: 996285 [No Abstract] [Full Text] [Related]
33. Tolerance to a behavioral effect of lysergic acid diethylamide and cross-tolerance to mescaline in the rat: absence of a metabolic component. Winter JC J Pharmacol Exp Ther; 1971 Sep; 178(3):625-30. PubMed ID: 5571911 [No Abstract] [Full Text] [Related]
34. Effect of mescaline and lysergic acid diethylamide on flicker discrimination in the rat. Schechter MD; Winter JC J Pharmacol Exp Ther; 1971 May; 177(2):461-7. PubMed ID: 5568801 [No Abstract] [Full Text] [Related]
36. Lack of cross-tolerance in rats among (-)delta9-trans-tetrahydrocannabinol(delta9-THC), cannabis extract, mescaline and lysergic acid diethylamide (LSD-25). Teresa M; Silva A; Carlini EA; Claussen U; Korte F Psychopharmacologia; 1968; 13(4):332-40. PubMed ID: 5722169 [No Abstract] [Full Text] [Related]
37. Interaction of LSD and other hallucinogens with dopamine-sensitive adenylate cyclase in primate brain: regional differences. Ahn HS; Makman MH Brain Res; 1979 Feb; 162(1):77-88. PubMed ID: 104775 [TBL] [Abstract][Full Text] [Related]
38. [Affective-cognitive structure and psychosis. New perspectives of the study of hallucination experience with psychodysleptics]. Andreoli A Ann Med Psychol (Paris); 1976 Apr; 134(4):501-22. PubMed ID: 952433 [TBL] [Abstract][Full Text] [Related]